Efforts to keep Iran from acquiring nuclear weapons could provoke dangerous reactions, including the country’s pursuit of other unconventional weapons systems. Owing to its highly developed pharmaceutical and biotech sectors, Iran has the technical capabilities for one such system—biological weaponry—within its grasp. It is unclear whether Tehran has already begun a biological weapons program, but the Iranian threat is grave enough to warrant serious consideration of a rigorous biological nonproliferation strategy that could be implemented in parallel with nuclear nonproliferation efforts. That strategy should be tailored specifically to Iran and focused on three sets of factors: those that facilitate proliferation, those that motivate proliferation, and those that shape the parameters according to which proliferation occurs.
The Bulletin elevates expert voices above the noise. But as an independent, nonprofit media organization, our operations depend on the support of readers like you. Help us continue to deliver quality journalism that holds leaders accountable. Your support of our work at any level is important. In return, we promise our coverage will be understandable, influential, vigilant, solution-oriented, and fair-minded. Together we can make a difference.